New research presented at ENDO 2026 suggests that completely cutting sugar from diets may have unintended health effects, highlighting the importance of balanced nutrition over extreme dietary bans. A new study presented at the Endocrine Society’s ENDO 2026 meeting suggests…
Groundbreaking research reveals even modest daily consumption of processed meats and sugary beverages significantly raises the risk of chronic diseases, challenging previous notions of safety thresholds. A study published in Nature Medicine has added to evidence that even small, regular…
Emerging evidence underscores the Mediterranean-style eating pattern as a practical, sustainable strategy for adults with type 2 diabetes seeking long-term weight management, emphasising balanced food choices over extreme carbohydrate restrictions. For adults with type 2 diabetes trying to lose weight,…
While foods rich in fibre, protein, and healthy fats, such as avocados and nuts, can boost the body’s production of GLP-1 hormone and aid blood sugar regulation, they do not replace prescription medications like Ozempic, according to experts. Semaglutide-based drugs…
Dr Jedha dispels myths around quick fixes, emphasising a personalised approach in managing type 2 diabetes, and cautions against unsupported supplements like berberine amid ongoing debates about diet and nerve health. Dr Jedha used a listener question-and-answer episode of the…
Short bursts of vigorous activity throughout the day, known as exercise snacks, may help improve blood sugar control and support heart health, offering a feasible alternative for those struggling to find time for longer workouts, according to new research. Short…
As individuals age past 55, natural changes in metabolism heighten the risk of blood sugar spikes, demanding increased vigilance in diet, activity, and health monitoring to maintain insulin sensitivity and prevent diabetes. After 55, it becomes more common for blood…
Amid growing interest in natural alternatives to Ozempic, experts highlight foods like avocado, chia seeds and apple cider vinegar for their potential to stimulate GLP-1 hormone, offering a nuanced approach to blood sugar management and metabolic health. People looking for…
Peptron has filed an investigational new drug application for PT403, a once-monthly semaglutide injection designed to improve obesity treatment adherence, marking a significant step in its development using the SmartDepot sustained-release technology. Peptron has moved a step closer to testing…
Enveda reports positive early safety data for ENV-308, an experimental oral drug inspired by exercise-induced molecule Lac-Phe, as it advances toward larger studies to assess its potential in weight regain prevention after GLP-1 therapy. Enveda has reported encouraging first human…
